JOSEPH M FECZKO

CIK 1319874 · Senior Vice President · last filed 2022-10-24

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.80M

Companies

3

Total Filings

73

Lifetime Open-Market Net

-$2.18M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CCXI Director 0 $10.22 $0 $60.3K 16 2022-10-24
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Director 120,000 $150.1K 7 2015-06-18
PFE Senior Vice President 412,019 $26.21 $10.80M -$2.39M 50 2009-03-16

Recent Filings · Page 8 of 8

73 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2007-02-26 PFE Grant (A) +47,030 $0 EDGAR
2007-02-15 PFE Mixed -$553.6K EDGAR
2007-01-03 PFE Grant (A) $0 EDGAR
Showing 7173 of 73
Page 8 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.